160 related articles for article (PubMed ID: 11522748)
1. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer.
Chari ST; Klee GG; Miller LJ; Raimondo M; DiMagno EP
Gastroenterology; 2001 Sep; 121(3):640-5. PubMed ID: 11522748
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
[TBL] [Abstract][Full Text] [Related]
3. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
[TBL] [Abstract][Full Text] [Related]
4. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.
Kautzky-Willer A; Thomaseth K; Ludvik B; Nowotny P; Rabensteiner D; Waldhäusl W; Pacini G; Prager R
Diabetes; 1997 Apr; 46(4):607-14. PubMed ID: 9075800
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia.
Oosterwijk C; van Hulst KL; Visser CJ; Woutersen RA; Lips CJ; van den Tweel JG; Höppener JW
Int J Cancer; 1997 Aug; 72(4):637-41. PubMed ID: 9259404
[TBL] [Abstract][Full Text] [Related]
6. The specificity of amylin for the diagnosis of pancreatic adenocarcinoma.
Brand RE; Ding XZ; Young CM; Adrian TE
Int J Gastrointest Cancer; 2002; 31(1-3):123-8. PubMed ID: 12622423
[TBL] [Abstract][Full Text] [Related]
7. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
Murakami M; Nagai Y; Tenjin A; Tanaka Y
Endocr J; 2018 Jun; 65(6):639-643. PubMed ID: 29643268
[TBL] [Abstract][Full Text] [Related]
8. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
[TBL] [Abstract][Full Text] [Related]
9. Islet amyloid polypeptide-producing pancreatic islet cell tumor. A clinical and biochemical characterization.
Stridsberg M; Wilander E; Oberg K; Lundqvist G; Eriksson B
Scand J Gastroenterol; 1992 May; 27(5):381-7. PubMed ID: 1326785
[TBL] [Abstract][Full Text] [Related]
10. Plasma islet amyloid polypeptide is not an effective tumor marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized.
Tateishi K; DiMagno EP; Klee GG
Clin Chem; 2001 Nov; 47(11):2071-3. PubMed ID: 11673391
[No Abstract] [Full Text] [Related]
11. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
Saruc M; Iki K; Pour PM
Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
[TBL] [Abstract][Full Text] [Related]
12. Islet hormone secretion in pancreatic cancer patients with diabetes.
Permert J; Larsson J; Fruin AB; Tatemoto K; Herrington MK; von Schenck H; Adrian TE
Pancreas; 1997 Jul; 15(1):60-8. PubMed ID: 9211494
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to islet amyloid polypeptide in diabetes.
Clark A; Yon SM; de Koning EJ; Holman RR
Diabet Med; 1991; 8(7):668-73. PubMed ID: 1833120
[TBL] [Abstract][Full Text] [Related]
14. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes?
Johnson KH; O'Brien TD; Westermark P
Diabetes; 1991 Mar; 40(3):310-4. PubMed ID: 1999270
[TBL] [Abstract][Full Text] [Related]
15. Islet amyloid polypeptide does not suppress pancreatic cancer.
Taylor AJ; Panzhinskiy E; Orban PC; Lynn FC; Schaeffer DF; Johnson JD; Kopp JL; Verchere CB
Mol Metab; 2023 Feb; 68():101667. PubMed ID: 36621763
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide in Psammomys obesus: lack of correlation between insulin resistance and plasma IAPP levels.
Duhault J; Boulanger M; Espinal J; Marquié G; Petkov P; Donev S; Jablenska R; Popov A
Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):535-40. PubMed ID: 8061570
[TBL] [Abstract][Full Text] [Related]
17. Novel serum tumor marker, RCAS1, in pancreatic diseases.
Yamaguchi K; Enjoji M; Nakashima M; Nakamuta M; Watanabe T; Tanaka M
World J Gastroenterol; 2005 Sep; 11(33):5199-202. PubMed ID: 16127752
[TBL] [Abstract][Full Text] [Related]
18. CA19-9 as a screening and diagnostic tool in symptomatic patients: the Japanese experience.
Satake K; Takeuchi T; Homma T; Ozaki H
Pancreas; 1994 Nov; 9(6):703-6. PubMed ID: 7846012
[TBL] [Abstract][Full Text] [Related]
19. [Postpartum evaluation of amylin secretion in gestational diabetes mellitus].
Kinalski M; Sledziewski A; Telejko B; Mironczuk K; Kretowski A; Kinalska I
Med Wieku Rozwoj; 2002; 6(1):75-80. PubMed ID: 12177515
[TBL] [Abstract][Full Text] [Related]
20. Islet amyloid polypeptide (amylin) does not seem to be directly involved in the development of gestational diabetes mellitus.
Grigorakis SI; Alevizaki M; Rapti E; Anastasiou E; Alevizaki CC; Souvatzoglou A
Gynecol Obstet Invest; 1997; 44(1):6-10. PubMed ID: 9251946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
